Cargando…
Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial
BACKGROUND: Patients with human papillomavirus-positive (HPV+) oropharyngeal squamous cell carcinoma (OPC) have substantially better treatment response and overall survival (OS) than patients with HPV-negative disease. Treatment options for HPV+ OPC can involve either a primary radiotherapy (RT) app...
Ejemplares similares
-
Early-stage squamous cell carcinoma of the oropharynx: Radiotherapy vs. Trans-Oral Robotic Surgery (ORATOR) – study protocol for a randomized phase II trial
por: Nichols, Anthony C, et al.
Publicado: (2013) -
Local Failure Rate in Oropharyngeal Carcinoma Patients Treated with Intensity-modulated Radiotherapy Without High-dose Clinical Target Volume
por: Almarzouki, Hatim, et al.
Publicado: (2018) -
Treatment for Recurrent Differentiated Thyroid Cancer: A Canadian Population Based Experience
por: Shokoohi, Aria, et al.
Publicado: (2020) -
Historical Perspective: How the Discovery of HPV Virus Led to the Utilization of a Robot
por: Morand, Grégoire B., et al.
Publicado: (2022) -
The role of brachytherapy for margin control in oral tongue squamous cell carcinoma
por: Ianovski, Ilia, et al.
Publicado: (2020)